69 related articles for article (PubMed ID: 17850390)
21. Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts.
Vallo S; Michaelis M; Gust KM; Black PC; Rothweiler F; Kvasnicka HM; Blaheta RA; Brandt MP; Wezel F; Haferkamp A; Cinatl J
BMC Res Notes; 2016 Sep; 9(1):454. PubMed ID: 27677700
[TBL] [Abstract][Full Text] [Related]
22. A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model.
Scheepbouwer C; Meyer S; Burggraaf MJ; Jose J; Molthoff CF
PLoS One; 2016; 11(8):e0161284. PubMed ID: 27533303
[TBL] [Abstract][Full Text] [Related]
23. Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing.
Zhang QI; Wang S; Yang D; Pan K; Li L; Yuan S
Oncol Lett; 2016 May; 11(5):3265-3272. PubMed ID: 27123101
[TBL] [Abstract][Full Text] [Related]
24. Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAs.
Zhang KX; Matsui Y; Lee C; Osamu O; Skinner L; Wang J; So A; Rennie PS; Jia WW
Gene Ther; 2016 May; 23(5):460-8. PubMed ID: 26905370
[TBL] [Abstract][Full Text] [Related]
25. Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.
Fazel J; Rötzer S; Seidl C; Feuerecker B; Autenrieth M; Weirich G; Bruchertseifer F; Morgenstern A; Senekowitsch-Schmidtke R
Cancer Biol Ther; 2015; 16(10):1526-34. PubMed ID: 26177233
[TBL] [Abstract][Full Text] [Related]
26. P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
Chi BH; Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chang IH
J Korean Med Sci; 2015 Mar; 30(3):308-16. PubMed ID: 25729255
[TBL] [Abstract][Full Text] [Related]
27. Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.
Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chi BH; Chang IH
J Korean Med Sci; 2014 Mar; 29(3):343-50. PubMed ID: 24616582
[TBL] [Abstract][Full Text] [Related]
28. Minimally invasive establishment of murine orthotopic bladder xenografts.
Jäger W; Moskalev I; Janssen C; Hayashi T; Gust KM; Awrey S; Black PC
J Vis Exp; 2014 Feb; (84):e51123. PubMed ID: 24561487
[TBL] [Abstract][Full Text] [Related]
29. Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression.
Delto JC; Kobayashi T; Benson M; McKiernan J; Abate-Shen C
Oncotarget; 2013 Feb; 4(2):269-76. PubMed ID: 23563166
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach.
Jäger W; Moskalev I; Janssen C; Hayashi T; Awrey S; Gust KM; So AI; Zhang K; Fazli L; Li E; Thüroff JW; Lange D; Black PC
PLoS One; 2013; 8(3):e59536. PubMed ID: 23555699
[TBL] [Abstract][Full Text] [Related]
31. Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.
Jäger W; Horiguchi Y; Shah J; Hayashi T; Awrey S; Gust KM; Hadaschik BA; Matsui Y; Anderson S; Bell RH; Ettinger S; So AI; Gleave ME; Lee IL; Dinney CP; Tachibana M; McConkey DJ; Black PC
J Urol; 2013 Oct; 190(4):1404-9. PubMed ID: 23500642
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue.
Park B; Jeong BC; Choi YL; Kwon GY; Lim JE; Seo SI; Jeon SS; Lee HM; Choi HY; Lee KS
Cancer Sci; 2013 May; 104(5):631-8. PubMed ID: 23384396
[TBL] [Abstract][Full Text] [Related]
33. An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment.
Kang MR; Yang G; Charisse K; Epstein-Barash H; Manoharan M; Li LC
J Vis Exp; 2012 Jul; (65):. PubMed ID: 22872227
[TBL] [Abstract][Full Text] [Related]
34. Mouse models of human bladder cancer as a tool for drug discovery.
Seager C; Puzio-Kuter AM; Cordon-Cardo C; McKiernan J; Abate-Shen C
Curr Protoc Pharmacol; 2010 Jun; Chapter 14():Unit14.14. PubMed ID: 22294368
[TBL] [Abstract][Full Text] [Related]
35. Mouse bladder wall injection.
Fu CL; Apelo CA; Torres B; Thai KH; Hsieh MH
J Vis Exp; 2011 Jul; (53):e2523. PubMed ID: 21775962
[TBL] [Abstract][Full Text] [Related]
36. RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer.
Seth S; Matsui Y; Fosnaugh K; Liu Y; Vaish N; Adami R; Harvie P; Johns R; Severson G; Brown T; Takagi A; Bell S; Chen Y; Chen F; Zhu T; Fam R; Maciagiewicz I; Kwang E; McCutcheon M; Farber K; Charmley P; Houston ME; So A; Templin MV; Polisky B
Mol Ther; 2011 May; 19(5):928-35. PubMed ID: 21364537
[TBL] [Abstract][Full Text] [Related]
37. Effect of nitroxoline on angiogenesis and growth of human bladder cancer.
Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO
J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277
[TBL] [Abstract][Full Text] [Related]
38. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers.
Tharakan ST; Inamoto T; Sung B; Aggarwal BB; Kamat AM
Biochem Pharmacol; 2010 Jan; 79(2):218-28. PubMed ID: 19682434
[TBL] [Abstract][Full Text] [Related]
39. Experimental rat bladder urothelial cell carcinoma models.
Arentsen HC; Hendricksen K; Oosterwijk E; Witjes JA
World J Urol; 2009 Jun; 27(3):313-7. PubMed ID: 19219611
[TBL] [Abstract][Full Text] [Related]
40. 1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth.
Inamoto T; Papineni S; Chintharlapalli S; Cho SD; Safe S; Kamat AM
Mol Cancer Ther; 2008 Dec; 7(12):3825-33. PubMed ID: 19074857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
